wbur.org
support wbur today!
Listen to this story
Manufacturing Depression?
photo

By guest host Jane Clayson:

Antidepressants are a multibillion dollar business in America and around the world. And therein, says psychotherapist Gary Greenberg, lies a big problem.

Pharmaceutical companies and researchers are casting their nets too wide to find new patients, calling normal, rational feelings a disease, says Greenberg. Some simple sadness, the occasional melancholy, is part of a normal life, he says, and getting rid of them may mean getting rid of the soul.

This hour On Point: manufacturing depression and the economy of melancholy.


Quotes from the Show:

“What really interested me about this experience [participating in a clinical trial study] was learning about the way that our experience of unhappiness or melancholy gets medicalized.”

“On the one hand there’re some real benefits to medicalizing suffering. … On the other hand, the cost of medicalizing depression, at least in my experience, was that the study was interested in everything except my experience.” Dr. Gary Greenburg

“The very reductionism that [Dr. Greenberg] disparages or at least critiques, is really necessary in order to make sense of the very complex data that every human brings into clinical work and clinical trials.” Dr. Jonathan Alpert

“The cost of not [medicalizing depression] is much higher.” Dr. Jonathan Alpert

“I am not against treating depression and unhappiness with drugs. … The sole question I am raising is whether their depression has to be medicalized in order to be treated.” Dr. Gary Greenburg

“Yes, I think it’s very important to distinguish illness from non-illness.” Peter Kramer

Guests:

Gary Greenberg, psychotherapist and uthor of an essay in the May issue of Harper’s Magazine called “Manufacturing Depression”;
Dr. Jonathan Alpert, Associate Director of the Depression Research Program at the Massachusetts General Hospital and Associate Professor of Psychiatry at Harvard Medical School.;
Dr. Peter Kramer, a clinical professor of psychiatry and human behavior at Brown University and author of “Against Depression,” “Listening to Prozac” and “Freud: Inventor of the Modern Mind.”

 
 

Comments are closed.

Recent Shows
After ‘No Child Left Behind’
Thursday, March 18, 2010

The Obama administration wants to rewrite No Child Left Behind. We’ll ask what’s coming for American education.

Comments [48]
 
The U.S.-Israel Blowup
Thursday, March 18, 2010

Top Pentagon brass complain the Israel-Palestinian impasse is undermining American interests. We’ll look at the US-Israel moment of crisis.

Comments [160]
On Point Blog
Sonny Rollins on Race and Jazz’s Future

Jazz legend Sonny Rollins joined us to reflect on his storied career and give us his thoughts on the future of music. To celebrate his 80th birthday, the hugely influential tenor saxophonist is embarking on yet another national tour.

More »
 
IED’s in Afghanistan: Hard Numbers

The Department of Defense provided On Point with some statistics about IED attacks in Afghanistan, where there has been an increase in the use of such weapons over the past 14 months. It’s striking to see the spike in numbers — from 2,677 IED incidents in 2007 to 8,159 last year.

More » | Comments [2]
 
Christopher Hill: U.S. Troop Withdrawal ‘On Schedule’

U.S. Ambassaor to Iraq Christopher Hill spoke with On Point live from Baghdad today as early voting gets underway, part of the run-up to Sunday’s elections. “So far so good,” Hill said, despite scattered violence. Hill said that the plan to withdraw U.S. combat troops by Sept. 1, and to leave only a residual advisory force of 50,000 or fewer, remains “very much on schedule.” Observers worry that a spike in violence could derail that timeline.

More »